Bill Text: NY S04497 | 2019-2020 | General Assembly | Introduced
Bill Title: Establishes the rare disease advisory council; advise and consult on policy matters relating to rare disease; twenty-one appointed members.
Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: (Passed) 2019-12-20 - approval memo.66 [S04497 Detail]
Download: New_York-2019-S04497-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 4497 2019-2020 Regular Sessions IN SENATE March 13, 2019 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to establishing the rare disease advisory council The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new article 2 27-L to read as follows: 3 ARTICLE 27-L 4 RARE DISEASE ADVISORY COUNCIL 5 Section 2799-u. Rare disease advisory council. 6 § 2799-u. Rare disease advisory council. 1. There shall be established 7 within the department a rare disease advisory council to advise and 8 consult on policy matters relating to rare disease. For the purposes of 9 this section, rare disease shall mean any disease or condition that 10 affects less than 200,000 people in the United States. 11 2. The council shall be composed of twenty-one members consisting of: 12 seventeen members shall be appointed by the governor, two members shall 13 be appointed by the speaker of the assembly, and two members shall be 14 appointed by the temporary president of the senate. The governor shall 15 designate the commissioner, or his or her designee, as chair of the 16 council, and the superintendent of the department of financial services, 17 or his or her designee, as co-chair of the council. The council shall at 18 all times include in its membership the following, which shall be 19 appointed by the governor: two physicians licensed and practicing in the 20 state with experience researching, diagnosing, or treating rare 21 diseases; one registered nurse or advanced practice registered nurse 22 licensed and practicing in the state with experience treating rare 23 diseases; two hospital administrators from hospitals in the state that 24 provide care to persons diagnosed with a rare disease, one of whom must 25 represent a hospital in which the scope of service focuses on rare EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD07491-01-9S. 4497 2 1 diseases of pediatric patients; three persons age eighteen or older who 2 either have a rare disease or are a caregiver of a person with a rare 3 disease; two representatives of a rare disease patient organization that 4 operates in the state; one pharmacist with experience with drugs used to 5 treat rare diseases; one representative of the biotechnology industry; 6 one representative of health insurance companies; one member of the 7 scientific community who is engaged in rare disease research; and one 8 genetic counselor with experience providing services to persons diag- 9 nosed with a rare disease or caregivers of those persons. 10 3. Members of the advisory council shall serve at the pleasure of the 11 appointing authority. Vacancies on the advisory council shall be filled 12 in the same manner as the original appointment. Members of the advisory 13 council shall receive no compensation for their services, but may be 14 reimbursed for necessary and actual expenses incurred in the performance 15 of their duties hereunder. 16 4. The advisory council shall meet at least three times in each calen- 17 dar year. The council shall meet at the request of its chairs. 18 5. The advisory council's duties may include, but are not limited to: 19 a. Convening public hearings, and receiving and considering reports 20 and testimony from individuals, the department, health care providers, 21 and public or private organizations recognized as having expertise in 22 rare diseases, as well as other interested parties, to assist the coun- 23 cil in developing recommendations under this section; 24 b. Studying the economic burden of the treatment of rare diseases with 25 regard to quality of care, health care coverage, and access to treatment 26 and services; 27 c. Developing recommendations pertaining to the impact of particular 28 health care coverage and the impact of particular coverage on the 29 provision of treatment and care services; 30 d. Identifying best practices for rare diseases that could improve 31 treatment of rare diseases in New York state; and 32 e. Developing a list of existing, publicly accessible resources on 33 research, diagnosis, treatment, coverage options, and education relating 34 to rare diseases, which shall be published on the department's website 35 upon completion. 36 6. The council shall prepare and submit a written report no later than 37 October first, two thousand twenty, and biennially thereafter, to the 38 governor, speaker of the assembly, and temporary president of the senate 39 that sets forth the findings and recommendations of the council on 40 matters within the scope of its duties as set forth in this section. 41 § 2. This act shall take effect immediately.
